SMITH & NEPHEW PLC

SMITH & NEPHEW PLC (SNN) is a US-listed equity tracked across major market indices. Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

FINOTAUR provides free research summaries, news aggregation, and fundamentals for SNN to support both active traders and long-term investors.